CellaVision AB (OTCPK:CLVSF)
$ 25.905 0 (0%) Market Cap: 476.81 Mil Enterprise Value: 467.45 Mil PE Ratio: 37.36 PB Ratio: 7.30 GF Score: 100/100

Q2 2024 CellaVision AB Earnings Call Transcript

Jul 19, 2024 / 09:00AM GMT
Release Date Price: $24.21 (+19.61%)
Simon Ostergaard
CellaVision AB - President, Chief Executive Officer

Thank you very much. So I'm Simon Ostergaard, President and CEO of CellaVision, and I have Magnus Blixt, our CFO with me today. We appreciate you listening in in this summer season to hear about our Q2 results that we are half halfway through 2024 results. So we are pleased to share the outcome.

Let's just jump right into it. So what we call the quarter in brief. Yeah, we landed the quarter at 11% growth. So organically, that was 10%. So hardly any FX impact on our results of SEK188 million in revenues. The EBITDA for the quarter, we landed at SEK60 million EBITDA corresponding to 32%. So just over our financial ambition of having 30% or more percent in EBITDA.

And I'd say the highlights, if we talk about the quarter here and there was stability, however, with some fluctuations. Top level, I would say we were very pleased to what we've seen in APAC across multiple countries. We see consistent performance out of EMEA. So that is positive. And then we saw this quarter had somewhat of a temporary slowdown in Americas.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot